SCHEMBL1710094

SCHEMBL1710094

CC1CC[C@@H](O)C1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17854853 1.00
SCHEMBL18611202 1.00
SCHEMBL1660645 1.00
SCHEMBL25910044 1.00
SCHEMBL18306536 1.00
SCHEMBL12225580 1.00
SCHEMBL902956 0.90 CA1 (0.41)
SCHEMBL2347884 0.90 CA1 (0.41)
SCHEMBL5868458 0.82 CA1 (0.42)
SCHEMBL12574437 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389542-B2 Dosage unit comprising a prostaglandin analog for treating constipation SUCAMPO AG (CH) 2013-03-05 US disclosed
US-20120088824-A1 DOSAGE UNIT COMPRISING A PROSTAGLANDIN ANALOG FOR TREATING CONSTIPATION SUCAMPO AG (CH) 2012-04-12 US disclosed
US-20090030072-A1 PHARMACEUTICAL COMBINATION OF OPIOID AND PROSTAGLANDIN COMPOUND SUCAMPO AG (CH) 2009-01-29 US disclosed
US-20090012165-A1 PHARMACEUTICAL COMBINATION OF NSAID AND PROSTAGLANDIN COMPOUND SUCAMPO AG (CH) 2009-01-08 US disclosed
US-7355064-B2 Method for preparing 15-keto-prostaglandin E derivative R-TECH UENO, LTD. (JP) 2008-04-08 US disclosed
US-20070276006-A1 Method for the treatment of gastrointestinal disorders SUCAMPO AG 2007-11-29 US disclosed
US-20070185206-A1 Method for preparing 15-keto-prostaglandin E derivative R-TECH UENO, LTD. (JP) 2007-08-09 US disclosed